Allianz Asset Management
RCUS icon

Allianz Asset Management’s Arcus Biosciences RCUS Stock Holding History

Allianz Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Buy
+82,458
New +$2.04M ﹤0.01% 1660
2024
Q4 		– Sell
-24,500
Closed -$375K – 2307
2024
Q3 		$375K Sell
24,500
-42,700
-64% -$673K ﹤0.01% 1932
2024
Q2 		$1.02M Sell
67,200
-31,100
-32% -$502K ﹤0.01% 1580
2024
Q1 		$1.86M Buy
98,300
+75,000
+322% +$1.3M ﹤0.01% 1206
2023
Q4 		$445K Sell
23,300
-13,700
-37% -$219K ﹤0.01% 1892
2023
Q3 		$664K Sell
37,000
-200
-0.5% -$4.02K ﹤0.01% 1832
2023
Q2 		$756K Sell
37,200
-33,400
-47% -$636K ﹤0.01% 1625
2023
Q1 		$1.29M Buy
+70,600
New +$1.35M ﹤0.01% 1568
2021
Q1 		– Sell
-7,900
Closed -$205K – 2269
2020
Q4 		$205K Sell
7,900
-45,105
-85% -$1.09M ﹤0.01% 1806
2020
Q3 		$908K Sell
53,005
-48,120
-48% -$1.08M ﹤0.01% 1452
2020
Q2 		$2.5M Buy
101,125
+403
+0.4% +$10.9K ﹤0.01% 1518
2020
Q1 		$1.4M Buy
+100,722
New +$1.25M ﹤0.01% 1656

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Allianz Asset Management's RCUS Position: Q2 2026 in Review

Allianz Asset Management opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 82,458 shares worth $2.54M. The stake represents ﹤0.01% of the portfolio and ranks #1660 among its holdings. This is a return to the name: Allianz Asset Management previously reported a position in RCUS as recently as Q3 2024.

Allianz Asset Management first reported a position in RCUS in Q1 2020 and has held it in 12 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Allianz Asset Management held 82,458 shares of Arcus Biosciences worth $2.54M as of Q2 2026.
  • Arcus Biosciences was a new Allianz Asset Management position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1660 holding.
  • Allianz Asset Management first reported a position in Arcus Biosciences in Q1 2020 and has held it in 12 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.